Gastrointestinal perforation after bevacizumab: a multi-site, single-institution study with a focus on survival

BACKGROUND: Bevacizumab-induced gastrointestinal perforation is a rare but potentially devastating adverse event that has generated limited data on overall survival. Yet, such survival data are critical in guiding management. METHODS: This multi-site, single-institution retrospective study focused o...

Descripción completa

Detalles Bibliográficos
Autores principales: Storandt, Michael H., Tran, Nguyen H., Ehret, Christopher J., Hanna, Mina, Jochum, Jacob, Moynagh, Michael R., Jatoi, Aminah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249159/
https://www.ncbi.nlm.nih.gov/pubmed/37291587
http://dx.doi.org/10.1186/s12957-023-03058-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249159/
https://www.ncbi.nlm.nih.gov/pubmed/37291587
http://dx.doi.org/10.1186/s12957-023-03058-x

Ejemplares similares